-
What are the characteristics of obstructive respiratory disorders?
increased resistance to airflow as a result of airway obstruction or airway narrowing...can result from secretions, edema, swelling of inner lumen of airways, bronchospasm or destruction of lung tissue
-
What are the two major changes that happen w/ emphysema? What does it result in?
- 1) loss of lung elasticity
- 2) hyperinflation of the lung
- ...results in dyspnea and the need for an incr. RR
-
Discuss characteristics of emphysema
- -aka "the pink puffer"
- -emphysema= narrowing of the airways and trapping of air and destructive changes in their walls
- -leads to progressive airflow limitation
- -elevated airway resistance
- -irreversible lung distention (loss of elasticity)
- -ABG insufficiency (pt. can't eliminate c02 fast enough, it's retained=resp. acidosis)
-
What ar the characteristics of Bronchitis?
- -aka "the blue bloater"
- -caused from exposure to irritants/infection...mainly SMOKE
- -effects small and large airways (not alveoli)
- -chronic inflammation causes mucous gland hypertrophy
- -hyperplasia, incr. viscid mucus
- -bronchial wall thickening
- -impaired air exchange
- -hypoxemia, incr. pC02 and acidosis
-
What are the characteristics of Asthma?
- -intermittent, reversible airway obstruction not affecting the alveoli
- -bronchospasm...edema in airway
- -result of physical and chemical irritants such as pollen, smoke, temp. changes, URI, activity, stress
- -may coexist w/ bronchitis and emphysema
-
What are some common assessments in the pt. w/ COPD?
- -cough
- -dyspnea w/ exertion
- -wheezing/crackles
- -sputum
- -wt. loss
- -barrel chest (1:1 ratio)
- -use of accessory muscles
- -hypercarbia: ABG may show chronic resp. acidosis (w/ COPD ABG's always show low O2 and might show high CO2
- -hypoxemia
- -PFT= decr. FEV1/FEV, incr. residual volume ('dead space')
- -cyanosis
- -clubbing
- -orthopnea
- -cardiac dysrhythmias
- -x-ray: flattened diaphragm/hyperinflation
-
What are the results of COPD?
- -blunting of chemoreceptors in CO2 retainers, need baseline ABGs to evaulate (normally our capacity to breathe is triggered by high CO2 levels...chemoreceptors in the medulla tell body to incr. RR)
- -pulmonary insufficiency
- -pulm HTN...cor pulmonale
-
Discuss collaborative care for a pt. w/ COPD
- -VS
- -O2< or equal to 2L/min
- -pulse ox
- -chest physiotherapy
- -HOB up
- -pursed-lip berathing
- -diaphragmatic breathing
- -monitor sputum
- -suction prn
- -humidification
- -small frequent meals of high calorie and high pro
- -encourage fluids 2-3L/day
- -monitor wt.
- -activity as tolerated
- -bronchodilatros by med neb or inhaler
- -steroids (common late in disease)
- -mucolytics
- -AB
- -lung reduction surgery (esp. w/ emphysema-removes lung tissue that no longer works)
-
What are some key pt. education points for the pt. w/ COPD?
- -stop smoking, aviod irritants, avoid crowds and infected ppl
- -recognize infection (such as sputum color change) and hypoxia
- -alternate rest w/ activity
- -demonstrate pursed-lip, diaphragmatic or abdominal breathing
- -instruct on proper inhaler use and O2 use
- -instruct in nutritional requirements, avoid gassy foods
- -flu vacc
- -dust w/ cloth to avoid odors
- -avoid temp extremes
- -pulmonary rehab- all about progressively incr. exercise tolerance to help recondition muscles to be more O2 efficient
- -
-
What are the goals of asthma therapy?
- -to imporve airflow, relieve s/sx and prevent episodes
- -teach pt. to assess sx severity at least BID w/ peak flowmeter and adjust drugs to manage inflammation and bronchospasms to prevent or relieve sx
- -establish a baseline peak expiratory flow (PEF) by measuiring PEF BID for 2-3 wks when asthma is well controlled and recording the results
- -once pt. gets a baseline of FEV1 (green zone) they can use it to monitor and make sure they stay w/in 80% or else use inhaler
-
Discuss proper administration of metered dose inhalers
- -shake prior to use (unless powder form)
- -have pt. exhale completely
- -hold inhaler 1-2 inches in front of mouth and breathe in deeply for about 3-5 sec while pressing down firmly on inhaler
- -hold breath for about 10 sec after
- -wait at least 1 min between puffs
- (can also use a spacer or put lips directly around inhaler)
-
What are LABA's? When should they be avoided?
- Long Acting Beta Agonists- NOT used as rescue inhaler...if they are it can make the attack worse and lead to death
- -examples of LABAs: formoterol (Foradil) and salmeterol (Serevent)
-
If you need a short-acting/rescue inhaler and a long acting which sequence do you use them?
short acting/rescue first followed by long acting bc you want to open airway immediately first
-
What is the proper technique for using dry powdered inhalers?
- -place lips over mouthpiece, breathe in forcefully (there is no propellant in inhaler, only your mouth pulls med in)
- -remove inhaler from mouth as soon as you have breathed in
- -never exhale/breathe out into your inhaler- your breath will cause powder to clump
- -never wash or place the inhaler in H20
- -never shake your inhaler
-keep in dry place at room temp - -if inhaler is preloaded discard after it is empty, insert capsule if not pre-loaded
- -bc drug is dry powder w/ no propellant you may not feel, smell, or taste as you inhale
-
Adrenergic Stimulants:
-Xopenex (Levalbuterol)
-Serevent (Salmeterol slow onset of action)
- -stimulate sympathetic (beta 2) receptors on the respiratory tract, resulting in smooth muscle relaxation and bronchodilation
- -when admon by metered-dose inhaler these drugs are the tx of choice for acute bronhial asthma
- -s/e: nervousness, irritability, tachycardia and cardiac dysrhythmias, palaitations, tremors, HTN
- -nursing considerations: -caution use in HTN, cardiovascular disease or dysrhythimia, hyperthyroidism or DM (may worsen)
- -when given by MDI, wait 1-2 min between puffs to allow airway to dilate, permitting the sencod dose to reach distal airways
- -rinse mouth after to reduce systemic absorbtion
- -observe for s/e and report for dose adjustment
- -LABAs like salmeterol are useful in preventing attacks, but have no value in treating an acute attack of wheezing
-
Methyxanthines (given PO or IV)
-theodur, theolair (theophylline), aminophylline
- -chemically related to caffeine, inducing respiratory smooth muscle relaxation
- -used primarily to prevent nocturnal asthma in adult clients
- -high potentail for toxicity: monitor serum levels!
- -s/e: anorexia, nausea, restlessness, insomnia, cardiac dysrhythmias, seizures (sx of toxicity)
- -nursing considerations: andmin PO doses w/ full glass of h2o or milk to minimize GI irritation
- -many drug interactions (barbitruates, anticonvulsants, thyroid hormone, beta blockers, bronchodilators)
- -IV aminophylline is incompatible w/ many other IV drugs, use a seperate line for infusion
-
Anticholinergics
Atropine, Atrovnet (ipratropium bromide), Sprivia (tiotropium bromide)
- -blocks input from the parasympathetic NS, atropine also dries mucous memb. secretions
- -s/e: N/V, abd. cramping, anxiety, dizziness, HA
- -nursing considerations: cautious use w/ glaucoma (bc they dilate pupils), prostatic hypertrophy or bladder obstruction
- -provide ice chips, fluids or candy as appropriate for dry mouth
- -place capsule in hadihaler (spirva) and press button to puncture
- -instruct pt to breathe in deeply and slowly, remove handihaler and hold breath for at least 10 sec, then exhale slowly, rinse mouth
-
Corticosteroids for asthma
- -anti-inflammatory effect helps prevent and tret accute episodes
- -cushingoid effects are minimized when inhaled
- rinse mouth after inhaler
-
Mast cell stabilizers (used for long term tx)
Cromolyn sodium (intal), Nedocromil (tilade)
- -inhibit inflammatory cells in the airway, blocking early and late responses for inhaled atigens, prevent bronchoconstriction in response to cold air
- -s/e: unpleasant taste
- -used only as prevention, not to tx acute attack
- -several wks may be required before beneficial effect is noted
-
Leukotrine Antagonist
Montelukast (Singulair) oral
- -given to slown down inflammatory sx, not a rescue med, given to prevent asthma attacks triggered by allergens
- -given orally, slow onset
-
Omalizumab (Xolair)
- -given sub-q every 2-3wk
- -idea is that it prevents IgE rxn from occuring...but it can actually cause anaphylaxis
- -purpose is prevention of allergen-triggered asthma attacks
- -s/e: large injections can cause site rxns w/ bruising, erythema, warmth, burning, stinging, pruritus, hives, pain, induration, and inflammation lasting up to 7 days
- -nursing considerations:
-
-admin at a facility equipped to handle anaphylaxis! (happen most often in the first 30-60 min after injection, keep pt there for at least 60 min so you can tx for anaphylaxis PRN) - -teach pt not to decr dose or stop taking other asthma drugs unless instructed by HCP
|
|